Search results
Bristol Myers says KRAS drug succeeds in key trial
BioPharma Dive via Yahoo Finance· 1 month agoConfirmatory results for Krazati, which Bristol Myers acquired via its buyout of Mirati, could help the drug win full approval while Amgen has been set...
A Patent Cliff Is Coming For Bristol Myers — Can Billions In New Products Fill The Gap?
Investor's Business Daily· 1 year agoIt's a new day at Bristol Myers Squibb, according to a company executive. But BMY stock remains...
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Motley Fool· 1 year agoShares in pharmaceutical company Bristol Myers Squibb (NYSE: BMY) are up a little more than 11% over...
Bristol Myers pours $100M into RNA drugs for cardiovascular diseases
BioPharma Dive via Yahoo Finance· 5 months agoBristol Myers Squibb has agreed to spend at least $100 million to expand a partnership aimed at...
Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug
Reuters via Yahoo Finance· 2 years agoA U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of...
US FDA allows J&J, Bristol Myers cell therapies as early cancer treatments (April 5)
Reuters via AOL· 1 month agoThe U.S. Food and Drug Administration has allowed the cell therapies of Johnson & Johnson and...
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
Reuters via AOL· 7 months ago(Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics...
FDA approves new Bristol Myers drug for lung cancer
BioPharma Dive via Yahoo Finance· 6 months agoAcquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top...
US FDA panel votes in favor of expanded use of Bristol Myers' CAR-T therapy
Reuters via Yahoo News· 2 months ago(Reuters) - Advisers to the U.S. Food and Drug Administration on Friday voted in favor of allowing...
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
Motley Fool· 5 months agoOn Nov. 28, the Food and Drug Administration (FDA) announced that it was opening an investigation...